APEX’s failure to prepare and submit the financial report for the first half of the fiscal year 2022 and the interim management discussion and analysis for the first half of the fiscal year 2022 within the
in the notification as follows : the first half of the fiscal year 2022 together with an interim management discussion and analysis This case is in the process of inquiry by the inquiry official
the first half of the fiscal year 2022 together with an interim management discussion and analysis This case is in the process of inquiry by the inquiry official. SEC Act S.300 in conjunction with 56
Director - General, The Excise Department, Ministry of Finance Director – General, Fiscal Policy Office, Ministry of Finance Inspector General, Ministry of Finance Fiscal Policy Advisor, Fiscal Policy
Director - General, The Excise Department, Ministry of Finance Director – General, Fiscal Policy Office, Ministry of Finance Inspector General, Ministry of Finance Fiscal Policy Advisor, Fiscal Policy
follows. 1. Net premium written for this year was 463.19 million baht, increased from last year by 199.63 million baht or 75.74%, due to the increase of gross premium written 141.11 million baht or 23.14
fiscal year 2019) is more than 20%, failed to prepare and submit the interim management discussion and analysis of the first half of the fiscal year 2019 through the transmission system of the Stock
company and its subsidiaries financial statement for the fiscal year 2015, ended as of December 31, 2015 which details are as following; Results 2015 (Revised Version) 2014 (Revised Version) Increase
committee member; (2) the Director-General of the Fiscal Policy Office, the Ministry of Finance or the Deputy Director-General of the Fiscal Policy Office, Senior Expert or Director of the department in the
IP_AC/001/2563 February 24, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited